Fatal Outcome of COVID-19 Relapse in a Fully Vaccinated Patient with Non-Hodgkin Lymphoma Receiving Maintenance Therapy with the Anti-CD20 Monoclonal Antibody Obinutuzumab: A Case Report

Few data are available regarding the effectiveness of anti-SARS-CoV-2 vaccine in immunocompromised patients. Vaccination may have a suboptimal efficacy in this population, in particular if patients are exposed to anti-B-cell therapy. We report the virological and clinical characteristics of a patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Calò, Federica, Onorato, Lorenzo, Pisaturo, Mariantonietta, Pinto, Antonio, Alessio, Loredana, Monari, Caterina, Minichini, Carmine, Arcamone, Manuela, Di Fraia, Alessandra, Atripaldi, Luigi, Tiberio, Claudia, Coppola, Nicola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9323164/
https://www.ncbi.nlm.nih.gov/pubmed/35891185
http://dx.doi.org/10.3390/vaccines10071021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9323164/
https://www.ncbi.nlm.nih.gov/pubmed/35891185
http://dx.doi.org/10.3390/vaccines10071021

Ejemplares similares